Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer

被引:147
作者
Dollins, Claudia M. [1 ]
Nair, Smita [1 ]
Boczkowski, David [1 ]
Lee, Jaewoo [1 ]
Layzer, Juliana M. [1 ]
Gilboa, Eli [2 ]
Sullenger, Bruce A. [1 ]
机构
[1] Duke Univ, Med Ctr, Duke Translat Res Inst, Dept Surg, Durham, NC 27710 USA
[2] Univ Miami, Dept Microbiol & Immunol, Sch Med, Miami, FL 33136 USA
来源
CHEMISTRY & BIOLOGY | 2008年 / 15卷 / 07期
关键词
D O I
10.1016/j.chembiol.2008.05.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We show that a molecular scaffold can be utilized to convert a receptor binding aptamer into a receptor agonist. Many receptors (including tumor necrosis receptor family members) are activated when they are multimerized on the cell surface. Molecular scaffolds have been utilized to assemble multiple receptor binding peptide ligands to generate activators of such receptors. We demonstrate that an RNA aptamer that recognizes OX40, a member of the tumor necrosis factor receptor superfamily, can be converted into a receptor-activating aptamer by assembling two copies on an olignucleotide-based scaffold. The OX40 receptor-activating aptamer is able to induce nuclear localization of nuclear factor-kappa B, cytokine production, and cell proliferation, as well as enhance the potency of dendritic cell-based tumor vaccines when systemically delivered to mice.
引用
收藏
页码:675 / 682
页数:8
相关论文
共 31 条
[21]   A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery [J].
Nimjee, Shahid M. ;
Keys, J. R. ;
Pitoc, G. A. ;
Quick, G. ;
Rusconi, C. P. ;
Sullenger, Bruce A. .
MOLECULAR THERAPY, 2006, 14 (03) :408-415
[22]   Aptamers: An emerging class of therapeutics [J].
Nimjee, SM ;
Rusconi, CP ;
Sullenger, BA .
ANNUAL REVIEW OF MEDICINE, 2005, 56 :555-+
[23]   ANTIMETASTATIC VACCINATION OF TUMOR-BEARING MICE WITH IL-2-GENE-INSERTED TUMOR-CELLS [J].
PORGADOR, A ;
GANSBACHER, B ;
BANNERJI, R ;
TZEHOVAL, E ;
GILBOA, E ;
FELDMAN, M ;
EISENBACH, L .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (03) :471-477
[24]   RNA aptamers as reversible antagonists of coagulation factor IXa [J].
Rusconi, CP ;
Scardino, E ;
Layzer, J ;
Pitoc, GA ;
Ortel, TL ;
Monroe, D ;
Sullenger, BA .
NATURE, 2002, 419 (6902) :90-94
[25]  
Santulli-Marotto S, 2003, CANCER RES, V63, P7483
[26]   Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40 [J].
Sugamura, K ;
Ishii, N ;
Weinberg, AD .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (06) :420-431
[27]   ACTIVATION OF CYTOTOXIC T CELLS BY NON-STIMULATING TUMOR-CELLS AND SPLEEN-CELL FACTORS(S) [J].
TALMAGE, DW ;
WOOLNOUGH, JA ;
HEMMINGSEN, H ;
LOPEZ, L ;
LAFFERTY, KJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (10) :4610-4614
[28]   SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT - RNA LIGANDS TO BACTERIOPHAGE-T4 DNA-POLYMERASE [J].
TUERK, C ;
GOLD, L .
SCIENCE, 1990, 249 (4968) :505-510
[29]   Tnf/tnfr family members in costimulation of T cell responses [J].
Watts, TH .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :23-68
[30]   Anti-OX40 (CD134) administration to nonhuman primates: Immunostimulatory effects and toxicokinetic study [J].
Weinberg, Andrew D. ;
Thalhofer, Colin ;
Morris, Nick ;
Walker, Joshua M. ;
Seiss, Donald ;
Wong, Scott ;
Axthelm, Michael K. ;
Picker, Louis J. ;
Urba, Walter J. .
JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) :575-585